Related Research Articles
Sir Gustav Victor Joseph Nossal is an Austrian-born Australian research biologist. He is famous for his contributions to the fields of antibody formation and immunological tolerance.
Peter Charles Doherty is an Australian immunologist and Nobel laureate. He received the Albert Lasker Award for Basic Medical Research in 1995, the Nobel Prize in Physiology or Medicine jointly with Rolf M. Zinkernagel in 1996 and was named Australian of the Year in 1997. In the Australia Day Honours of 1997, he was named a Companion of the Order of Australia for his work with Zinkernagel. He is also a National Trust Australian Living Treasure. In 2009 as part of the Q150 celebrations, Doherty's immune system research was announced as one of the Q150 Icons of Queensland for its role as an iconic "innovation and invention".
Rolf Martin Zinkernagel is Professor of Experimental Immunology at the University of Zurich. He was awarded the Nobel Prize in Physiology or Medicine in 1996 for the discovery of how the immune system recognizes virus-infected cells.
Sir Gregory Paul Winter is a Nobel Prize-winning English molecular biologist best known for his work on the therapeutic use of monoclonal antibodies. His research career has been based almost entirely at the MRC Laboratory of Molecular Biology and the MRC Centre for Protein Engineering, in Cambridge, England.
CD1D is the human gene that encodes the protein CD1d, a member of the CD1 family of glycoproteins expressed on the surface of various human antigen-presenting cells. They are non-classical MHC proteins, related to the class I MHC proteins, and are involved in the presentation of lipid antigens to T cells. CD1d is the only member of the group 2 CD1 molecules.
Richard Henderson is a Scottish molecular biologist and biophysicist and pioneer in the field of electron microscopy of biological molecules. Henderson shared the Nobel Prize in Chemistry in 2017 with Jacques Dubochet and Joachim Frank.
TAP-associated glycoprotein also known as tapasin or TAPBP is a protein that in humans is encoded by the TAPBP gene.
Charles Alderson Janeway, Jr. (1943–2003) was a noted immunologist who helped create the modern field of innate immunity. A member of the National Academy of Sciences, he held a faculty position at Yale University's Medical School and was an HHMI Investigator.
Michael Sela was an Israeli immunologist of Polish Jewish origin. He was the W. Garfield Weston Professor of Immunology at the Weizmann Institute of Science in Rehovot. He was a president of the Weizmann Institute of Science.
HLA class II histocompatibility antigen gamma chain also known as HLA-DR antigens-associated invariant chain or CD74, is a protein that in humans is encoded by the CD74 gene. The invariant chain is a polypeptide which plays a critical role in antigen presentation. It is involved in the formation and transport of MHC class II peptide complexes for the generation of CD4+ T cell responses. The cell surface form of the invariant chain is known as CD74. CD74 is a cell surface receptor for the cytokine macrophage migration inhibitory factor (MIF).
Philippa "Pippa" Marrack, Ph.D, FRS is an English immunologist and academic, based in the United States, best known for her research and discoveries pertaining to T cells. Marrack is the Ida and Cecil Green Professor and chair of the Department of Biomedical Research at National Jewish Health and a Distinguished Professor of immunology and microbiology at the University of Colorado Denver.
CD82, or KAI1, is a human protein encoded by the CD82 gene.
Peter S. Kim is an American scientist. He was president of Merck Research Laboratories (MRL) 2003–2013 and is currently Virginia & D.K. Ludwig Professor of Biochemistry at Stanford University, Institute Scholar at Stanford ChEM-H, and Lead Investigator of the Infectious Disease Initiative at the Chan Zuckerberg Biohub.
Sir Christopher Martin Dobson was a British chemist, who was the John Humphrey Plummer Professor of Chemical and Structural Biology in the Department of Chemistry at the University of Cambridge, and Master of St John's College, Cambridge.
Hugh O'Neill McDevitt ForMemRS was an immunologist and Professor of Microbiology and Immunology at Stanford University School of Medicine.
James Patrick Allison is an American immunologist and Nobel laureate who holds the position of professor and chair of immunology and executive director of immunotherapy platform at the MD Anderson Cancer Center at the University of Texas.
Terence Howard Rabbitts FRS FMedSci is currently Professor of Molecular Immunology at the Institute of Cancer Research, London.
Helen Kim Bottomly is an immunologist and the former president of Wellesley College, serving from August 2007 to July 2016. Bottomly was the first scientist to become a president at Wellesley College. She has been a member of the American Academy of Arts and Sciences since 2009. She chaired the board of directors of the Consortium on Financing Higher Education and was a member of the advisory council of the National Institutes of Allergy and Infectious Diseases at the National Institutes of Health. In May 2018, she was appointed as the chair of the board of the trustees for the Fulbright University Vietnam, which she stepped down from in 2019.
Vincenzo Cerundolo was the Director of the Medical Research Council (MRC) Human Immunology Unit at the University of Oxford, at the John Radcliffe Hospital and a Professor of Immunology at the University of Oxford. He was also a Supernumerary Fellow at Merton College, Oxford. He was known for his discoveries in processing and presentation of cancer and viral peptides to T cells and lipids to invariant NKT cells. Cerundolo died of lung cancer on 7 January 2020.
Cornelis Joseph Maria Melief is a globally recognised immunology expert specialising in cancer immunology and immunotherapy, with special focus on therapeutic cancer vaccines. He is Emeritus Professor, former head of the Department of Immunohematology and Blood Transfusion at the Leiden University Medical Center, and Chief Scientific Officer at ISA Therapeutics in Netherlands. He is known for his work in the field of cancer immunology, devising new cancer therapies based on the activation of the patient’s own immune system.
References
- 1 2 "Peter Cresswell, PhD, FRS" . Retrieved 20 December 2019.
- ↑ "Peter Cresswell, PhD". Howard Hughes Medical Institute. Retrieved 20 December 2019.
- ↑ "Peter Cresswell" . Retrieved 20 December 2019.
- ↑ "About the PNAS Member Editor" . Retrieved 20 December 2019.
- ↑ "NKT Therapeutics Broadens Scientific Advisory Board with Three New Appointments". 27 July 2009. Retrieved 20 December 2019.
- ↑ Rajendrani Mukhopadhyay (December 2012). "Meet Peter Cresswell, a new associate editor for The Journal of Biological Chemistry".
- ↑ "Peter Cresswell, Ph.D." Cancer Research Institute. Retrieved 20 December 2019.
- ↑ "IOM Elects 65 New Members, Five Foreign Associates" . Retrieved 20 December 2019.
- ↑ "Peter Cresswell". The Royal Society. Retrieved 20 December 2019.
- ↑ "Three join National Academy of Sciences". Yale Medicine. Summer 2001.
- ↑ "Royal Society recognizes excellence in science". 9 June 2009. Retrieved 20 December 2019.
- ↑ "Member directory Chapter C" (PDF). American Academy of Arts and Sciences. Retrieved 20 December 2019.
